| 标题 |
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:Yu Hu; Xiaofan Liu; Hu Zhou; Shujie Wang; Ruibin Huang; et al 出版日期:2024-06-14 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)